Table 2.
Distribution of MRSA and MR-CoNS isolates among 227 study volunteer subjects
| Subjects carrying MRSA | Subjects carrying MR-CoNS | |||
|---|---|---|---|---|
| n | (%) | n | (%) | |
| Total | 19 | (8·4) | 123 | (54·2) |
| Total nasal | 17 | (7·5) | 110 | (48·5) |
| Total skin | 13 | (5·7) | 28 | (12·3) |
| Exclusively nasal | 6 | (2·6) | 95 | (41·8) |
| Exclusively skin | 2 | (0·9) | 13 | (5·7) |
| Nasal + skin | 11 | (4·8) | 15 | (6·6) |
MRSA, Methicillin-resistant Staphylococcus aureus; MR-CoNS, methicillin-resistant coagulase-negative staphylococci.